Jason B. Daly, EVP, Chief Legal Officer at Amneal Pharmaceuticals, sold AMRX on Aug 11, 2026
Data as of Oct 27
▼ SELL$117K6,613 shares at $17.70Jason B. Daly EVP, Chief Legal OfficerAMRX Amneal Pharmaceuticals, Inc.
- Traded
- Aug 11, 2026
- Disclosed
- Aug 13, 2026
- Filed
- 2 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
AMRX since disclosure
+24.1%
after the sale
Similar stocks (XLV) since disclosure
+6.4%
XLV — its sector index fund
Change in closing price from Aug 13, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▼ SELLJason B. Daly EVP, Chief Legal OfficerAMRX Amneal Pharmaceuticals, Inc.$3.7Mdisclosed Aug 13 · filed 1 day after the trade